Ukraine
Tuberculosis profile
| High HIV burden | High MDR-TB burden |
Population  2012 46 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 6.1 (6–6.2) 13 (13–14)
Mortality (HIV+TB only) 1.1 (0.86–1.5) 2.5 (1.9–3.2)
Prevalence  (includes HIV+TB) 62 (29–110) 137 (65–236)
Incidence  (includes HIV+TB) 42 (35–51) 93 (77–112)
Incidence (HIV+TB only) 4.8 (3.9–5.7) 10 (8.6–13)
Case detection, all forms (%) 96 (81–120)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 11 030 (35) Relapse 3 650 (44)
Smear-negative 17 398 (55) Treatment after failure    
Smear-unknown / not done     Treatment after default    
Extrapulmonary 3 344 (11) Other 4 579 (56)
Other          
Total new 31 772   Total retreatment 8 229  
           
Other (history unknown) 5 568        
Total new and relapse 35 422   Total cases notified 45 569  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 3.0 2.0  
Age < 15 19 204  
Laboratories 2012
Smear (per 100 000 population) 1.8
Culture (per 5 million population) 9.4
Drug susceptibility testing (per 5 million population) 4.5
Is second-line drug susceptibility testing available? Yes, in country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 58   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary 76  
Retreatment 34  
TB/HIV 2012 Number (%)
TB patients with known HIV status 34 181 (75)
HIV-positive TB patients 4 726 (14)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 3 406 (72)
HIV-positive TB patients on antiretroviral therapy (ART) 3 336 (71)
HIV-positive people screened for TB    
HIV-positive people provided with IPT 14 352  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 14 (14–15) 32 (31–33)
MDR-TB cases among notified pulmonary
TB cases
4 100 (3 900–4 300) 2 600 (2 600–2 700)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 11 185 (77%) 5 925 (72%) 17 110
Laboratory-confirmed MDR-TB cases 1 614 1 908 6 934
Patients started on MDR-TB treatment     7 672
Financing TB control 2013
National TB programme budget (US$ millions) 85
% Funded domestically 49%
% Funded internationally 4%
% Unfunded 47%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-20 Data: www.who.int/tb/data